Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM

Rohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, Kelly Li, Jin J Zhou, Faaizah Arshad, Clair Blacketer, Mary G Bowring, Fan Bu, Michael Cook, David A Dorr, Talita Duarte-Salles, Scott L DuVall, Thomas Falconer, Tina E French, Elizabeth E Hanchrow, Scott Horban, Wallis CY Lau, Jing Li, Yuntian Liu, Yuan Lu, Kenneth KC Man, Michael E Matheny, Nestoras Mathioudakis, Michael F McLemore, Evan Minty, Daniel R Morales, Paul Nagy, Akihiko Nishimura, Anna Ostropolets, Andrea Pistillo, Jose D Posada, Nicole Pratt, Carlen Reyes, Joseph S Ross, Sarah Seager, Nigam Shah, Katherine Simon, Eric YF Wan, Jianxiao Yang, Can Yin, Seng Chan You, Martijn J Schuemie, Patrick B Ryan, George Hripcsak, Harlan Krumholz, Marc A Suchard

Open source

DOI: 10.1136/bmjmed-2023-000651
Published: 2023-10
Container: BMJ Medicine
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjmed-2023-000651,
  title = {Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM},
  author = {Rohan Khera and Lovedeep Singh Dhingra and Arya Aminorroaya and Kelly Li and Jin J Zhou and Faaizah Arshad and Clair Blacketer and Mary G Bowring and Fan Bu and Michael Cook and David A Dorr and Talita Duarte-Salles and Scott L DuVall and Thomas Falconer and Tina E French and Elizabeth E Hanchrow and Scott Horban and Wallis CY Lau and Jing Li and Yuntian Liu and Yuan Lu and Kenneth KC Man and Michael E Matheny and Nestoras Mathioudakis and Michael F McLemore and Evan Minty and Daniel R Morales and Paul Nagy and Akihiko Nishimura and Anna Ostropolets and Andrea Pistillo and Jose D Posada and Nicole Pratt and Carlen Reyes and Joseph S Ross and Sarah Seager and Nigam Shah and Katherine Simon and Eric YF Wan and Jianxiao Yang and Can Yin and Seng Chan You and Martijn J Schuemie and Patrick B Ryan and George Hripcsak and Harlan Krumholz and Marc A Suchard},
  year = {2023},
  journal = {BMJ Medicine},
  doi = {10.1136/bmjmed-2023-000651},
  url = {https://doi.org/10.1136/bmjmed-2023-000651}
}

RIS

TY  - JOUR
TI  - Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
AU  - Rohan Khera
AU  - Lovedeep Singh Dhingra
AU  - Arya Aminorroaya
AU  - Kelly Li
AU  - Jin J Zhou
AU  - Faaizah Arshad
AU  - Clair Blacketer
AU  - Mary G Bowring
AU  - Fan Bu
AU  - Michael Cook
AU  - David A Dorr
AU  - Talita Duarte-Salles
AU  - Scott L DuVall
AU  - Thomas Falconer
AU  - Tina E French
AU  - Elizabeth E Hanchrow
AU  - Scott Horban
AU  - Wallis CY Lau
AU  - Jing Li
AU  - Yuntian Liu
AU  - Yuan Lu
AU  - Kenneth KC Man
AU  - Michael E Matheny
AU  - Nestoras Mathioudakis
AU  - Michael F McLemore
AU  - Evan Minty
AU  - Daniel R Morales
AU  - Paul Nagy
AU  - Akihiko Nishimura
AU  - Anna Ostropolets
AU  - Andrea Pistillo
AU  - Jose D Posada
AU  - Nicole Pratt
AU  - Carlen Reyes
AU  - Joseph S Ross
AU  - Sarah Seager
AU  - Nigam Shah
AU  - Katherine Simon
AU  - Eric YF Wan
AU  - Jianxiao Yang
AU  - Can Yin
AU  - Seng Chan You
AU  - Martijn J Schuemie
AU  - Patrick B Ryan
AU  - George Hripcsak
AU  - Harlan Krumholz
AU  - Marc A Suchard
PY  - 2023
JO  - BMJ Medicine
DO  - 10.1136/bmjmed-2023-000651
UR  - https://doi.org/10.1136/bmjmed-2023-000651
ER  -

APA

Khera, R., Dhingra, L. S., Aminorroaya, A., Li, K., Zhou, J. J., Arshad, F., Blacketer, C., Bowring, M. G., Bu, F., Cook, M., Dorr, D. A., Duarte-Salles, T., DuVall, S. L., Falconer, T., French, T. E., Hanchrow, E. E., Horban, S., Lau, W. C., Li, J., Liu, Y., Lu, Y., Man, K. K., Matheny, M. E., Mathioudakis, N., McLemore, M. F., Minty, E., Morales, D. R., Nagy, P., Nishimura, A., Ostropolets, A., Pistillo, A., Posada, J. D., Pratt, N., Reyes, C., Ross, J. S., Seager, S., Shah, N., Simon, K., Wan, E. Y., Yang, J., Yin, C., You, S. C., Schuemie, M. J., Ryan, P. B., Hripcsak, G., Krumholz, H., & Suchard, M. A. (2023). Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM. BMJ Medicine. https://doi.org/10.1136/bmjmed-2023-000651

Source records

crossref · retrieved 2026-09-27T01:37:03.923Z